Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VTL | Vital Therapies, Inc. | 1.50% | 13.51 | 3.3% | $792.68m | |
| AMGN | Amgen Inc. | 2.36% | 204.02 | 1.3% | $749.47m | |
| GILD | Gilead Sciences, Inc. | 0.43% | 63.14 | 0.9% | $384.23m | |
| CELG | Celgene Corporation | 1.53% | 94.74 | 1.3% | $360.74m | |
| ILMN | Illumina, Inc. | 0.49% | 286.17 | 3.5% | $321.19m | |
| BIIB | Biogen Inc. | 1.78% | 231.68 | 1.3% | $305.34m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.11% | 184.94 | 1.9% | $260.38m | |
| EXAS | Exact Sciences Corporation | 1.35% | 119.82 | 24.1% | $245.81m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.66% | 110.85 | 2.0% | $238.74m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.28% | 296.85 | 2.6% | $212.35m | |
| A | Agilent Technologies, Inc. | 2.18% | 71.11 | 1.6% | $206.33m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.44% | 124.95 | 14.7% | $156.17m | |
| INCY | Incyte Corporation | 3.11% | 83.12 | 2.5% | $97.22m | |
| BMRN | BioMarin Pharmaceutical Inc. | 6.65% | 76.50 | 4.3% | $91.98m | |
| SGEN | Seattle Genetics, Inc. | 3.25% | 79.20 | 6.5% | $90.21m |
Company Profile
Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.